S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Perceptive Advisors/Q3 2023

Perceptive Advisors

Period: Q3 2023 Β· Filed: 2023-11-14
View on SEC EDGAR β†—
AUM
$3.00B
Total portfolio value
Positions
97
Reported securities
Top Holding
FOLD
11.2% $336.8M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
FOLDAMICUS THERAPEUTICS INC$336.8M11.23%β€”β€”
11.2%
CERECEREVEL THERAPEUTICS HLDNG I$220.2M7.35%β€”β€”
7.3%
IMVTIMMUNOVANT INC$146.4M4.88%$34.64$38.79+12.0%
4.9%
ACLXARCELLX INC$142.3M4.75%$34.66β€”
4.8%
NUVLNUVALENT INC$113.2M3.78%$45.81$123.73+170.1%
3.8%
SLNOSOLENO THERAPEUTICS INC$90.7M3.03%$26.48β€”
3.0%
LIANYLIANBIO$85.8M2.86%$0.00$0.12
2.9%
AKROAKERO THERAPEUTICS INC$81.9M2.73%β€”β€”
2.7%
INBXINHIBRX INC$78.1M2.61%β€”$97.58
2.6%
ALDXALDEYRA THERAPEUTICS INC$75.8M2.53%$6.06$2.27-62.5%
2.5%
ARGXARGENX SE$74.0M2.47%$487.32$939.68+92.8%
2.5%
PCVXVAXCYTE INC$68.5M2.28%$49.04$58.39+19.1%
2.3%
VRNAVERONA PHARMA PLC$65.3M2.18%β€”β€”
2.2%
CBAYCYMABAY THERAPEUTICS INC$60.3M2.01%β€”β€”
2.0%
MGTXMEIRAGTX HLDGS PLC$55.6M1.86%$4.65$13.92+199.3%
1.9%
IOVAIOVANCE BIOTHERAPEUTICS INC$54.4M1.82%$4.43$4.31-2.7%
1.8%
LYRAXXXXLYRA THERAPEUTICS INC$49.9M1.66%β€”β€”
1.7%
AMLXAMYLYX PHARMACEUTICALS INC$49.2M1.64%$18.12$18.27+0.8%
1.6%
BBIOBRIDGEBIO PHARMA$46.1M1.54%$25.41$77.19+203.8%
1.5%
MDTMEDTRONIC PLC$46.0M1.53%$71.07$83.19+17.1%
1.5%
ROIVROIVANT SCIENCES LTD$44.6M1.49%$10.52$35.13+233.9%
1.5%
IRONDISC MEDICINE INC$42.1M1.40%$45.65$76.26+67.0%
1.4%
IMTXIMMATICS N.V$40.4M1.35%$10.79$9.95-7.8%
1.4%
APGEAPOGEE THERAPEUTICS INC$38.9M1.30%$20.40$132.91+551.5%
1.3%
CRNXCRINETICS PHARMACEUTICALS IN$37.6M1.25%$27.14$42.23+55.6%
1.3%
RVMDREVOLUTION MEDICINES INC$36.6M1.22%$26.17$189.24+623.1%
1.2%
SWTXSPRINGWORKS THERAPEUTICS INC$35.1M1.17%β€”β€”
1.2%
AXSMAXSOME THERAPEUTICS INC$33.7M1.12%$66.85$244.31+265.5%
1.1%
HRMYHARMONY BIOSCIENCES HLDGS IN$32.6M1.09%$32.44$37.26+14.9%
1.1%
RAPTRAPT THERAPEUTICS INC$31.9M1.06%β€”β€”
1.1%

Quarter-on-Quarter Activity

Q3 2023 vs. Q2 2023

New Positions (8)

TickerIssuerNotionalSince Filing
APGEAPOGEE THERAPEUTICS INC$38.9M+551.5%
RVMDREVOLUTION MEDICINES INC$36.6M+623.1%
TNGXTANGO THERAPEUTICS INC$27.2M
RYZBRAYZEBIO INC$17.3M
EOLSEVOLUS INC$13.6M
RYTMRHYTHM PHARMACEUTICALS INC$8.7M
NVAXPUTNOVAVAX INC$3.8M
EYPTPUTEYEPOINT PHARMACEUTICALS INC$2.5M

Exited Positions (8)

TickerIssuerNotional
RETAREATA PHARMACEUTICALS INC$68.3M
VIRVIR BIOTECHNOLOGY INC$48.0M
ILMNILLUMINA INC$27.2M
MRTXMIRATI THERAPEUTICS INC$26.0M
BMRNBIOMARIN PHARMACEUTICAL INC$22.8M
ITCIINTRA-CELLULAR THERAPIES INC$15.6M
ISEEIVERIC BIO INC$6.6M
QTRXQUANTERIX CORP$2.9M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
VERUXXXXVERU INC$0.7M+1112.6%
VRNAVERONA PHARMA PLC$64.6M+701.4%
TVTXTRAVERE THERAPEUTICS INC$2.2M+340.8%
BHVNBIOHAVEN LTD$11.9M+134.3%
SRPTCALLSAREPTA THERAPEUTICS INC$12.9M+125.4%
ARGXARGENX SE$47.1M+118.3%+92.8%
AXSMAXSOME THERAPEUTICS INC$14.2M+77.4%+265.5%
PNTPUTPOINT BIOPHARMA GLOBAL INC$2.0M+60.0%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
CYPHLEAP THERAPEUTICS INC$-1.8M-92.3%
APLSPUTAPELLIS PHARMACEUTICALS INC$-73.9M-87.7%
MDGLMADRIGAL PHARMACEUTICALS INC$-51.8M-58.9%
AKROCALLAKERO THERAPEUTICS INC$-85.2M-58.8%
XENEXENON PHARMACEUTICALS INC$-26.0M-49.5%
NBTXNANOBIOTIX$-0.5M-47.6%
NTRANATERA INC$-10.1M-46.2%
AMLXAMYLYX PHARMACEUTICALS INC$-55.9M-44.8%+0.8%
← Back to Hedge Funds